Solas C - Search Results

1

HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study.

Perrin S, Cremer J, Faucher O, Reynes J, Dellamonica P, Micallef J, Solas C, Lacarelle B, Stretti C, Kaspi E, Robaglia-Schlupp A, Nicolino-Brunet C, Tamalet C, Lévy N, Poizot-Martin I, Cau P, Roll P. Perrin S, et al. Among authors: solas c. PLoS One. 2012;7(12):e53035. doi: 10.1371/journal.pone.0053035. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285253 Free PMC article. Clinical Trial.

2

Relationship between efficacy, tolerance, and plasma drug concentration of ritonavir in children with advanced HIV infection.

Dumon C, Solas C, Thuret I, Chambost H, Lacarelle B, Michel G, Durand A. Dumon C, et al. Among authors: solas c. Ther Drug Monit. 2000 Aug;22(4):402-8. doi: 10.1097/00007691-200008000-00007. Ther Drug Monit. 2000. PMID: 10942179

3

'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.

Duran S, Solas C, Spire B, Carrieri MP, Fuzibet JG, Costagliola D, Lacarelle B, Moatti JP; Cohort Manif 2000 Study Group. Duran S, et al. Among authors: solas c. AIDS. 2001 May 25;15(8):1075-7. doi: 10.1097/00002030-200105250-00024. AIDS. 2001. PMID: 11399998 Clinical Trial. No abstract available.

4

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.

Lafeuillade A, Solas C, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Lafeuillade A, et al. Among authors: solas c. HIV Clin Trials. 2002 Jan-Feb;3(1):27-35. doi: 10.1310/WMWL-6W9Y-PXV2-X148. HIV Clin Trials. 2002. PMID: 11819183

5

High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimen.

Solas C, Basso S, Poizot-Martin I, Ravaux I, Gallais H, Gastaut JA, Durand A, Lacarelle B. Solas C, et al. J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):374-7. doi: 10.1097/00126334-200204010-00008. J Acquir Immune Defic Syndr. 2002. PMID: 11917242

6

Pharmacokinetic interaction between lopinavir/r and amprenavir in salvage therapy.

Basso S, Solas C, Quinson AM, Ravaux I, Poizot-Martin I, Bacconier J, Durand A, Lacarelle B. Basso S, et al. Among authors: solas c. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):115-7. doi: 10.1097/00126334-200209010-00015. J Acquir Immune Defic Syndr. 2002. PMID: 12352158 No abstract available.

7

Experience of a combination including indinavir 400 mg plus ritonavir 200 mg twice daily in HIV-infected patients: pharmacokinetic data.

Solas C, Petit N, Orticoni M, Durand A, Gastaut JA, Lacarelle B. Solas C, et al. Pathol Biol (Paris). 2002 Nov;50(9):565-7. doi: 10.1016/s0369-8114(02)00342-5. Pathol Biol (Paris). 2002. PMID: 12490421

8

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.

Solas C, Lafeuillade A, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Solas C, et al. Antimicrob Agents Chemother. 2003 Jan;47(1):238-43. doi: 10.1128/AAC.47.1.238-243.2003. Antimicrob Agents Chemother. 2003. PMID: 12499197 Free PMC article. Clinical Trial.

9

HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen.

Lafeuillade A, Solas C, Chadapaud S, Hittinger G, Poggi C, Lacarelle B. Lafeuillade A, et al. Among authors: solas c. J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):462-4. doi: 10.1097/00126334-200304010-00018. J Acquir Immune Defic Syndr. 2003. PMID: 12640207 No abstract available.

10

Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.

Solas C, Poizot-Martin I, Drogoul MP, Ravaux I, Dhiver C, Lafeuillade A, Allegre T, Mokhtari M, Moreau J, Lepeu G, Petit N, Durand A, Lacarelle B. Solas C, et al. Br J Clin Pharmacol. 2004 Apr;57(4):436-40. doi: 10.1046/j.1365-2125.2003.02020.x. Br J Clin Pharmacol. 2004. PMID: 15025741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters